Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

FHTX Foghorn Therapeutics Inc. Common Stock
$5.60 -1.41% -0.08
Notify me if price changes either direction
Interactive Brokers Logotype

Buy FHTX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 332.2M
Enterprise value 154.4M
Trailing PE -3.5443037974684
Forward PE -5.7791686
PEG Ratio 0.1831223628692
Enterprise to EBITDA -1.855
Enterprise to revenue 6.298
Price to book MRQ -3.9367824488612
Price to sales TTM 13.547503

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 24.5M
EBITDA -83225000
Diluted EPS TTM -1.14
Total Cash (MRQ) 180.3M
Current ratio (MRQ) 2.164
Operating Cash Flow (TTM) -88347000

FHTX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent FHTX News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.